PIPE-307, Aiming to Restore Myelin, Found Safe in Phase 1 Trial
PIPE-307, an investigational myelin-restoring medication being developed by Pipeline Therapeutics for the treatment of multiple sclerosis (MS), appears to be…
sNfL May Predict Multiple Sclerosis Disease Activity in Individual Patients
In the first year of therapy, sNfL concentrations were reduced rapidly in treated patients and decreased only marginally in…
Stuart Schlossman
How MS Affects Your Brain
Multiple sclerosis (MS) is an unpredictable and long lasting disease of the central nervous system that disrupts communication between…
Stuart Schlossman
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
Pascal Benkert 1, Stephanie Meier 2, Sabine Schaedelin 1, Ali Manouchehrinia 3, Özgür Yaldizli 2, Aleksandra Maceski 2, Johanna Oechtering…
Stuart Schlossman
Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders
Read complete article here Abstract Background: B cells can contribute to immune-mediated disorders. Targeting CD20 has proved to be efficacious in…
Stuart Schlossman
Tevogen Bio™ to Study Potential Use of its T cell Technology in Epstein-Barr Virus and Multiple Sclerosis
January 20, 2022 04:26 PM Eastern Standard Time METUCHEN, N.J.–(BUSINESS WIRE)–Tevogen Bio, a clinical stage biotechnology company specializing in cell…
Stuart Schlossman
Study: DNA Methylation in T-cells Affected by MS and Its Treatments
by Marisa Wexler MS | February 1, 2022 Multiple sclerosis (MS) is characterized by changes in methylation — a type…
Stuart Schlossman
EBV and MS: Is Multiple Sclerosis Really ‘Long Mono’?
New research strengthens the connection between the Epstein-Barr virus, the cause of most cases of mononucleosis, and MS. By Trevis…
Stuart Schlossman
When MS Attacks the Spinal Cord
Spinal cord lesions are more commonly seen in progressive forms of multiple sclerosis, and they can result in an increased…
Stuart Schlossman
Hydroxychloroquine May Slow PPMS Progression, Study Shows
NOTE: Please always speak with your MS healthcare team before making any decisions to try new treatments. ——————————————— Oct 2021…
Stuart Schlossman
